James Hoekstra to Coronary Artery Disease
This is a "connection" page, showing publications James Hoekstra has written about Coronary Artery Disease.
Connection Strength
0.373
-
Roe MT, Kikano G, Miller CD, Hoekstra JW. Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition. Postgrad Med. 2008 Jul; 120(2):67-78.
Score: 0.257
-
Glauser J, Erickson J, Bhatt D, Lindsell C, Gibler B, Hoekstra J, Pollack C, Hollander J, Peacock WF. Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. Congest Heart Fail. 2007 May-Jun; 13(3):142-8.
Score: 0.059
-
Cohen M, Mahaffey KW, Pieper K, Pollack CV, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ. A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2006 Oct 03; 48(7):1346-54.
Score: 0.057